Rationale: Upregulation of endothelial vascular cell adhesion molecule (VCAM)-1 and the subsequent increase in monocyte recruitment constitute critical events in atherogenesis. We have recently shown that in human coronary artery endothelial cells (HCAECs) regulated expression of VCAM-1 depends, to a significant extent, on expression and function of the Ca 2؉ -permeable channel transient receptor potential canonical (TRPC)3, regardless of the ability of the stimulatory signal to induce regulated Ca 2؉ influx, leading to the hypothesis that TRPC3 constitutive, rather than regulated function, contributes to the underlying signaling mechanism. Objective: The present studies addressed this important question and gathered mechanistic insight on the signaling coupling constitutive TRPC3 function to VCAM-1 expression.
A therosclerosis is a chronic inflammatory disease of the vascular wall that constitutes a major cause of cardiovascular morbidity/mortality in western societies. 1 Over the last 2 decades, basic and clinical research underscored the critical role of vascular inflammation not only in initiation but also in progression of the disease and extent of its complications. Recruitment of circulating monocytes to the endothelium and their migration into the subintima is a fundamental event in early and advanced stages of atherosclerosis. 2, 3 Monocyte adhesion to endothelium requires interaction of the integrin ␣ 4 ␤ 1 on the monocyte with vascular cell adhesion molecule (VCAM)-1 on the endothelial cell. 4 Expression of VCAM-1 is upregulated in response to proinflammatory/ proatherogenic stimuli, such as nucleotides, interleukin-1␤, and oxidized low density lipoproteins, among others. 5 In human coronary artery endothelial cells (HCAECs) nucleotides activate P2Y 2 receptors to induce VCAM-1 through a mechanism that in part requires Ca 2ϩ signaling. 6 -10 Recently, 11 we showed that in HCAECs native TRPC3, a member of the transient receptor potential canonical (TRPC) family of nonselective cation channels, 12 contributes to the Ca 2ϩ influx that follows stimulation of P2Y 2 receptors, and that TRPC3 expression is fundamental in the signaling underlying ATPinduced VCAM-1 and monocyte adhesion. Treatment with ATP also promotes augmented TRPC3 expression, and an increase in constitutive cation influx is detectable even after the acute phase of channel stimulation has subsided. 11 Tumor necrosis factor (TNF)␣ also induces VCAM-1 in endothelium from most vascular beds 13 including HCAECs. 11 Despite the fact that TNF␣ signaling is not associated to regulation of Ca 2ϩ influx, 14 omission of extracellular Ca 2ϩ impairs the ability of TNF␣ to induce VCAM-1 in HCAECs. 11 These observations, together with the fact that in native and heterologous expression systems TRPC3 forms channels endowed with high constitutive, nonregulated activity, 12, 15 led us to hypothesize that TRPC3 constitutive, rather than regulated, function contributes to the mechanism driving VCAM-1 expression and monocyte adhesion in these cells. In the present work, we show that those 2 events depend, to a significant extent, on upregulated expression of native TRPC3 and the consequent gain in constitutive channel function. Mechanistic insight is provided suggesting a role for the calmodulin (CAM)/calmodulin-dependent kinase (CAMK)II axis in coupling constitutive TRPC3 function to activation of NFB. We discuss our findings within the context of the potential impact of upregulated expression of a channel endowed with high constitutive activity in atherogenesis.
Methods
Cell culture and transfections, immunoblotting, cell ELISA, monocyte adhesion, Ca 2ϩ imaging, and electrophysiological measurements were performed essentially as described previously. 11, 16, 17 Protocols, composition of solutions and buffers, sequence of small interfering (si)RNA oligonucleotides, and source of antibodies are provided in the Online Data Supplement, available at http://circres.ahajournals.org.
Results
Treatment of HCAECs with TNF␣ (10 ng/mL) resulted in robust expression of VCAM-1 already after 3 hours of treatment, remaining elevated for up to 16 hours (Online Figure I ; also elsewhere 11, 18 ). TNF␣ effect was manifest in total (whole lysate, Figure 1A , ϩCa 2ϩ lanes) and plasma membrane ( Figure 1B ) VCAM-1, with increased adhesion of U937 monocytes to HCAECs ( Figure 1C ). When studying the role of regulated Ca 2ϩ influx on ATP-induced VCAM-1, 11 we found that omission of Ca 2ϩ in the extracellular bath (nominally Ca 2ϩ -free medium) also impaired the ability of TNF␣ to induce plasma membrane VCAM-1. The experiments in Figure 1 show that not only surface VCAM-1 ( Figure 1B and elsewhere 11 ) but also total VCAM-1 protein ( Figure 1A , ϪCa 2ϩ lanes; normalized densitometric values in the absence of Ca 2ϩ : 0.081Ϯ0.010 0.096Ϯ0.015 VCAM-1/ GAPDH, for control versus TNF␣-treated cells, respectively, not statistically different, nϭ3) and monocyte adhesion (Figure 1C) were reduced when Ca 2ϩ was omitted in the bath. This was unexpected considering that TNF␣, unlike ATP, is not associated to regulated Ca 2ϩ influx in endothelium. In fact, acutely challenging HCAECs with TNF␣ did not result in noticeable Ca 2ϩ release or influx ( Figure 2A ) or changes in whole-cell currents (inward currents at Ϫ60 mV: Ϫ1.10Ϯ 0.14 versus Ϫ1.40Ϯ0.10 pA/pF, outward currents at ϩ60 mV: 2.10Ϯ0.20 versus 1.90Ϯ0.11 pA/pF, for control versus TNF␣-treated cells, respectively; nϭ6 to 8 cells/condition, PϽ0.07, not statistically significant; see also Online Figure II, A). Because TRPC3 is a nonselective cation channel that can permeate Na ϩ under physiological conditions (see 12 and references therein), we tested the possibility that membrane depolarization subsequent to TRPC3-mediated Na ϩ influx could be masking any potential effect of TNF␣ on Ca 2ϩ entry in the Fura-2 measurements, as in those experiments membrane potential is not clamped and thus subject to changes depending on ion movements across the membrane. Cells were challenged with TNF␣ but in the presence of N-methyl-D-glucamine as a substitute for Na ϩ in the bath -thus preventing or minimizing membrane depolarization-; still, no changes in Ca 2ϩ influx were observed (not shown). Altogether, these findings strongly suggested that if Ca 2ϩ influx contributed to TNF␣-dependent expression of VCAM-1, it was likely through constitutive, nonregulated channel function. To more directly explore this, HCAECs were exposed to TNF␣ (10 ng/mL, 3 hour) but in the presence of the Ca 2ϩ channel blockers Gd 3ϩ or SKF96365. As shown in Figure 2B and 2C, those blockers, at concentrations that abolish Ca 2ϩ influx in HCAECs 11 (regulated and constitutive Ca 2ϩ influx were inhibited by 94Ϯ2% with 10 mol/L Gd 3ϩ or 30 mol/L SKF96365; see Online Figure III , B) markedly reduced TNF␣-induced VCAM-1 and monocyte adhesion.
Combining real-time fluorescence measurements of Ba 2ϩ influx with a siRNA approach we demonstrated that in HCAECs constitutive cation (Ca 2ϩ /Ba 2ϩ ) entry is mediated by native TRPC3 channels 11 (and Online Figure III , C). Using this strategy, we examined if TRPC3-mediated nonregulated cation influx contributed to TNF␣ actions in these cells. HCAECs were transfected with TRPC3 siRNA (see the Online Data Supplement and Online Figure IV ) and 48 hours later surface VCAM-1 and monocyte adhesion were evaluated. Figure 2B and 2C shows that both events were reduced when TRPC3 was knocked down. (Expression of TNF␣ receptor type-1 [TNFR1], evaluated by immunoblot, did not change under the different experimental conditions [normalized densitometric meanϮSEM value for TNFR1/GAPDH was 1.032Ϯ0.29, for conditions including omission of Ca 2ϩ in the bath, channel blockers, or siRNA transfections].) importantly, knockdown of the close TRPC3 relatives TRPC6 and -7 had no effect ( Figure 2B and 2C; also Online Figure  V ). Moreover, cotransfecting HCAECs with TRPC3 siRNA and a TRPC3 encoding plasmid, rescued the siRNA effect (normalized densitometric values for total VCAM-1: 0.433Ϯ0.070 versus 0.395Ϯ0.080 VCAM-1/GAPDH, for control TNF␣-treated versus "rescued" TNF␣-treated cells, respectively; not statistically different, nϭ3; see also Online Figure VI ). Intercellular adhesion molecule (ICAM)-1, but not E-selectin, was also upregulated after 3 hours of treatment of HCAECs with TNF␣ (Online Figure VII) . Knockdown of TRPC3 drastically reduced TNF␣-induced ICAM-1 total protein (Online Figure VII) but not surface ICAM-1 (not shown). To examine whether TRPC3 also contributed to the action of other proinflammatory/proatherogenic stimuli in HCAECs, we tested the effect of interleukin (IL)-1␤ and lipopolysaccharide on VCAM-1 expression. After 3 hours of treatment, IL-1␤ (10 ng/mL) but not lipopolysaccharide (from Escherichia coli, 1 g/mL), induced VCAM-1 expression to a level comparable to that of TNF␣ (Online Figure  VIII) . TRPC3 knockdown reduced IL-1␤ effect by Ϸ41% (normalized densitometric values for IL-1␤-induced VCAM-1: 0.352Ϯ0.040 versus 0.156Ϯ0.030, for cells transfected with nonspecific oligos versus TRPC3 siRNA, respectively; PϽ0.05, nϭ3). Treatment with TNF␣ also resulted in a gain in basal cation entry (Ϸ2-fold increase in rate of constitutive Ba 2ϩ influx, Figure 3A and 3B), which correlated with a prominent increase in whole-cell current density ( Figure 3C ; Online Figure II , B) and amount of TRPC3 protein ( Figure 3D ). Remarkably, those effects were absent when TRPC3 was knocked down before TNF␣ treatment ( Figure 3A through 3C). Constitutive Ba 2ϩ influx remained unaffected by knockdown of TRPC6 or 7 (Online Figure III, C) , supporting the notion that constitutive cation influx in HCAECs is mostly mediated by TRPC3. 11 TRPC4 and -7 proteins were also increased by TNF␣, whereas TRPC1 was reduced to almost undetectable levels (Online Figure IX ). TRPC5 and -6 remained unaltered (data not shown). To gather preliminary insight regarding expression of native TRPC3 in vivo, we examined TRPC3 by immunohistochemistry in aortic root sections from apolipoprotein (Apo)E Ϫ/Ϫ and wild-type (C57BL/6) mice (Online Figure X; see expanded Methods section in the Online Data Supplement). As expected, ApoE Ϫ/Ϫ mice showed unequivocal lesions which stained positive for neutral lipids and exhibited significant macrophage infiltration (Online Figure X , A through C). TRPC3 immunoreactivity in sections from wild-type animals, when present, was barely detectable or only manifested as few positive cells. TRPC3 staining, although diffuse, was more notorious in sections from ApoE Ϫ/Ϫ mice (Online Figure X, D through F).
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Constitutive Ca 2ϩ influx in HCAECs is masked by an efficient Ca 2ϩ buffering system. 11 Despite that acute stimulation of these cells with TNF␣ did not induce any noticeable Ca 2ϩ influx, the possibility remained that if TNF␣ were to promote weak activation of native TRPC3, the subsequent Ca 2ϩ entry might be rapidly coped by the buffering apparatus thus going undetectable under our experimental conditions. However, even when Ba 2ϩ was used as a surrogate for Ca 2ϩ (Ba 2ϩ is not substrate for buffering systems, enters cells unidirectionally and magnifies the otherwise unnoticeable basal cation influx; see 15 ), acutely challenging HCAECs with TNF␣ did not result in detectable Ba 2ϩ entry (rate of Ba 2ϩ
Figure 1. Requirement on extracellular Ca 2؉ for TNF␣induced VCAM-1 expression and monocyte adhesion.
HCAECs were treated with TNF␣ (10 ng/mL, 3 hour) in the presence (ϩCa 2ϩ ) or absence (-Ca 2ϩ ) of extracellular Ca 2ϩ and processed for: immunodetection of VCAM-1 in whole cell lysates (A), ELISA detection of surface VCAM-1 (B), and monocyte adhesion (C). A, The doublet (Ϸ90 to 105 kDa) represents different degrees of glycosylation of VCAM-1 (see elsewhere 43 ). The position of the 76-and 102-kDa molecular mass markers is indicated. B, *PϽ0.01; **PϽ0.02. C, *PϽ0.01; **PϽ0.02; ***PϽ0.03 (C). When indicated, cells were incubated with anti-VCAM-1 (10 g/mL) or anti-VEGFR1 (10 g/mL; negative control) antibodies for 45 minutes before monocyte addition, as described elsewhere. 11 influx: 0.015Ϯ0.002 versus 0.011Ϯ0.003 ratio units/min, for nontreated versus TNF␣-treated cells, respectively; PϽ0.08, not statistically different; nϭ25 to 30 cells). To more directly assess whether TNF␣ had any effect on TRPC3, we used HEK293 cells stably overexpressing human TRPC3 (T3-HEK293 19 ; Online Figure XI, B ). As expected, T3-HEK293 cells responded to the diacylglycerol analog 1-oleyl-2-acetylsn-glycerol (OAG) (a potent TRPC3 activator in overexpression systems 15 ) with robust regulated Ba 2ϩ influx, a manifestation of overexpressed TRPC3 16, 20 (data not shown); nevertheless, acute treatment with TNF␣ did not affect basal cation influx (rate of constitutive Ba 2ϩ influx: 0.030Ϯ0.002 versus 0.027Ϯ0.001 ratio units/min, for nontreated versus acutely TNF␣-treated cells, respectively; PϽ0.07, not statistically different, nϭ45 to 60 cells). We next asked whether the increase in TRPC3 expression, and thus in constitutive Ca 2ϩ influx, is sufficient to promote VCAM-1 expression. To address this, 2 alternative approaches were undertaken. First, we examined VCAM-1 expression in T3-HEK293 cells.
Because of the high levels of TRPC3, T3-HEK293 cells exhibit robust constitutive cation entry compared to wild-type cells (rate of Ba 2ϩ influx: 0.030Ϯ0.002 versus 0.013Ϯ0.002 ratio units/min, for T3-HEK293 versus wild-type HEK293 cells, respectively; PϽ0.001, nϭ45 to 55 cells; see also elsewhere 16, 20 ) . As shown in Figure 4A , VCAM-1 expression in wild-type HEK293 cells was significantly augmented (Ϸ1.5-fold over basal, PϽ0.05) after 16 hour of treatment with TNF␣ (10 ng/mL). Notably, whereas basal VCAM-1 was not significantly different from wild-type cells, the time course for TNF␣-induced VCAM-1 in T3-HEK293 cells was left-shifted, with a trend to be significantly augmented already at 3 hour (1.5-fold over basal) and a marked increase compared with wild-type cells at 16 hour (Ϸ2.2-fold over corresponding basal, PϽ0.05). Notably, in wild-type and T3-HEK293 cells, TNF␣-induced VCAM-1 was decreased in the presence of 10 mol/L Gd 3ϩ ( Figure 4A ). Second, we examined basal and TNF␣-induced VCAM-1 in HCAECs transiently overexpressing TRPC3. Cells were transfected HCAECs were acutely exposed to TNF␣ (10 ng/mL) to evaluate changes in intracellular Ca 2ϩ . Shown is the average response of 12 cells, representative of 51 cells from four independent experiments. Before ending the recording, cells were challenged with ATP (100 mol/L) to test for responsiveness (see also 10, 29 ). B, HCAECs were treated with TNF␣ (10 ng/mL, 3 hour) in the presence or absence of the channel blockers Gd 3ϩ (10 mol/L) or SKF96365 (SKF) (30 mol/L) and processed for detection of surface VCAM-1. Alternatively, cells were transfected with nonspecific oligonucleotides (NSsiRNA); siRNA specific for TRPC3 (TRPC3siRNA), TRPC6 (TRPC6siRNA), or TRPC7 (TRPC7siRNA); or cotransfected with TRPC3 siRNA plus TRPC3-HA cDNA (TRPC3 Rescue) (see expanded Methods in the Online Data Supplement) and, 48 hours later, treated with TNF␣ (10 ng/mL, 3 hour) and surface VCAM-1 detected by ELISA. *PϽ0.01; **PϽ0.02. C, HCAECs were treated as in B and then processed for evaluation of monocyte adhesion. *PϽ0.01; **PϽ0.02. Shown are results from 3 independent experiments. with a hemagglutinin epitope (HA)-tagged version of human TRPC3 (T3-HA, 1 g; see also Online Figure XI, C). In mammalian cells, T3-HA trafficking, function, and regulation are indistinguishable from the nontagged channel. 16, 20 T3-HA-transfected HCAECs, but not mock-transfected cells, exhibited a robust increase in constitutive and OAG-induced Ba 2ϩ influx (rate of constitutive Ba 2ϩ influx: 0.026Ϯ0.02 versus 0.012Ϯ0.002 ratio units/sec; rate of OAG-induced Ba 2ϩ influx: 0.052Ϯ0.002 versus 0.015Ϯ0.003 ratio units/ sec, for T3-HA-transfected versus mock-transfected cells, respectively; PϽ0.01, nϭ30 to 45 cells per group). (Despite expressing TRPC3/6/7 proteins, 11 HCAECs do not exhibit OAG-induced Ca 2ϩ influx, likely because native TRPC3/6/7 proteins are inhibited by protein kinase [PK]C 22-24, which is massively activated by the diacylglycerol analog. We have shown that native TRPC7 in lymphocytes 17, 25 and native TRPC3 in HCAECs 26 respond to OAG only after PKC inhibition. Thus, under the present conditions [no PKC inhibition], OAG-induced Ba 2ϩ influx is considered a mani-festation of overexpressed TRPC3.) Whereas no differences were observed in basal VCAM-1 expression, TNF␣-induced VCAM-1 was significantly higher in T3-HA-transfected HCAECs compared to mock transfected cells ( Figure 4B) .
In most endothelial cells, regulated expression of VCAM-1 (and ICAM-1) is driven by nuclear factor (NF)B. 26 NFB activation involves its release from the inhibitory IB␣ protein, which requires phosphorylation of IB␣ by IB kinase (IKK)␤ followed by IB␣ degradation. 27 Treatment of HCAECs with TNF␣ (10 ng/mL) resulted in rapid (peaking within 5 minutes) and sustained NFB activation, as indicated by the extent of IB␣ phosphorylation/degradation (Online Figure XII) ; both events were suppressed by the IKK inhibitor hypoestoxide (50 mol/L, not shown), which also abolished TNF␣-induced VCAM-1 (normalized densitometric values: 0.420Ϯ0.060 versus 0.050Ϯ0.010 VCAM-1/ GAPDH, in the absence or presence of 50 mol/L hypoestoxide, respectively). Because our data suggested a contribution of TRPC3 constitutive function to the mecha- nism driving VCAM-1 expression and considering that NFB activation depends, directly or indirectly, on Ca 2ϩ influx, 28 we speculated that TRPC3 might be required for activation of NFB in HCAECs. As shown in Figure 5 , knockdown of TRPC3 markedly decreased TNF␣-induced IB␣ phosphorylation (1.8-versus 5.1-fold increase over control, for TRPC3siRNA-versus NSsiRNA-transfected cells, respectively; nϭ3, PϽ0.05) and degradation (1.6-versus 2.8-fold reduction of control, for TRPC3siRNA-versus NSsiRNAtransfected cells, respectively; nϭ3, PϽ0.05). Conversely, transient overexpression of TRPC3-HA in HCAECs enhanced TNF␣-induced IB␣ phosphorylation (ϩ1.3-fold) and degradation (ϩ1.4-fold) compared with mock-transfected cells (nϭ3, PϽ0.05; Figure 6 ). Based on studies indicating that in several cell types, including endothelium (see elsewhere 29 ), Ca 2ϩ influx-dependent activation of NFB is often associated to CAM and CAMKs, particularly CAMKII and CAMKIV, we undertook a pharmacological approach to gather preliminary insight on their potential participation in mediating the role of constitutive Ca 2ϩ influx in activation of NFB by TNF␣ in HCAECs. We focused on 2 of the earliest events associated to TNF␣-dependent activation of the canonical NFB route: phosphorylation of IB␣ and its upstream regulator, IKK␤. As shown in Figure 7A , TNF␣induced phosphorylation of IKK␤ was suppressed by the CAM inhibitor W-7 (50 mol/L), the general CAMK antagonist KN-62 (10 mol/L) and SKF96365 (which prevents constitutive Ca 2ϩ influx in HCAECs; Online Figure III, B ; and elsewhere 11 ). Importantly, knockdown of TRPC3 also prevented TNF␣-induced IKK␤ phosphorylation. Similarly to IKK␤, phosphorylation of IB␣ was completely abrogated by W-7 and SKF96365, and partially reduced by KN-62 ( Figure 7B ). Inhibition of NADPH oxidases with apocynin (0.5 mmol/L) resulted in partial decrease of IB␣ phosphorylation ( Figure 7B ). (In HCAECs, membrane-associated, apocynin-sensitive NADPH oxidases [Nox2/Nox4A] are the major sources of TNF␣-induced ROS. 30 ) Neither basal nor TNF␣ stimulated phosphorylation of IB␣ were affected by Gö6976 (1 mol/L), a selective inhibitor of Ca 2ϩ -dependent PKCs, or the phorbol ester PMA (0.1 mmol/L) (Online Figure XIII ).
Discussion
The findings in the present work show that in HCAECs, TNF␣-induced VCAM-1 and monocyte adhesion depend, to a considerable extent, on nonregulated Ca 2ϩ influx through a mechanism that requires the constitutive function of TRPC3 channels. This is supported by several lines of evidence. First, maneuvers that prevent constitutive Ca 2ϩ entry into cells or knockdown of native TRPC3 protein markedly impaired TNF␣-induced VCAM-1 and monocyte adhesion. Second, regulated expression of VCAM-1 was enhanced in 2 different TRPC3-overexpression systems in the absence of receptordependent channel activation. Third, knockdown of TRPC3 drastically reduced activation of NFB, which controls VCAM-1 expression in HCAECs.
Constitutive function of TRPC3 is inhibited by micromolar concentrations of the nonselective channel blockers SKF96365 and Gd 3ϩ . 12 Whereas none of these compounds is specific for TRPC3, they reduced VCAM-1 expression and monocyte adhesion to the same extent as knockdown of TRPC3 did, supporting the notion that TRPC3 constitutive function contributes to those events. The partial reduction of surface VCAM-1 and monocyte adhesion when TRPC3 is knocked down can be attributed to incomplete downregulation of TRPC3 under our experimental conditions. However, constitutive Ca 2ϩ influx, but not VCAM-1 or monocyte binding, was completely suppressed by Gd 3ϩ and SKF96365, suggesting that in HCAECs, those processes are also regulated by alternative Ca 2ϩ -independent mechanisms (see also elsewhere 11 ). Importantly, our studies also show that in HCAECs TNF␣-dependent activation of NFB requires constitutive Ca 2ϩ influx, presumably through TRPC3, which in HCAECs accounts for most of the constitutive Ca 2ϩ entry ( Figure 3B and 3C; Online Figure III, C; and elsewhere 11 ). Indeed, TRPC3 knockdown significantly reduced TNF␣induced phosphorylation of IB␣ and its upstream activator, IKK␤. Pharmacological inhibition of CAM or CAMKs drastically reduced TNF␣-dependent phosphorylation of IKK␤ and its target IB␣, pointing to the CAM/CAMK axis as a likely candidate in the mechanism coupling TRPC3-mediated constitutive Ca 2ϩ influx to IKK␤ phosphorylation and NFB activation. Whereas KN-62 is equally efficient in inhibiting CAMKII or CAMKIV, 31 the predominant nuclear versus cytosolic localization of CAMKIV 31 suggests that is presumably CAMKII the one linking constitutive Ca 2ϩ influx to NFB. Interestingly, CAMKII is emerging as a critical CAMK in endothelial dysfunction within the context of cardiovascular disease. 32 The partial reduction of TNF␣induced IB␣ phosphorylation by apocynin indicates that NADPH oxidase-mediated production of ROS is necessary for full activation of NFB. (As indicated above, membraneassociated, apocynin-sensitive NADPH oxidases are the major sources of TNF␣-induced ROS in HCAECs. 30 ) However, Figure 6 . Overexpression of TRPC3 enhances TNF␣-induced activation of NFB. HCAECs transiently transfected with human TRPC3-HA (T3-HA-Tx) or vector alone (pcDNA3.1) (Mock-Tx) were treated with TNF␣ (10 ng/mL, 5 minutes) and processed for immunodetection of phosphorylated (pIB␣) and total IB␣ (IB␣). Blots are representative from three independent experiments. Membranes were reprobed for GAPDH to control for protein loading. Position of the 38-and 52-kDa molecular mass markers is indicated. Figure 7 . Role of Ca 2؉ , CAM/CAMK, ROS, and TRPC3 in TNF␣-induced activation of NFB. HCAECs were treated with TNF␣ (10 ng/mL, 5 minutes) in the absence or presence (15 minutes preincubation) of W-7 (50 mol/L), KN-62 (10 mol/L), SKF96365 (SKF) (30 mol/L) or apocynin (0.5 mmol/L); alternatively, cells were transfected with nonspecific oligonucleotides (NSsiRNA) or TRPC3 siRNA (TRPC3siRNA), and 48 hours later treated with TNF␣ (10 ng/mL, 5 minutes). Cells were then processed for immunodetection of phosphorylated IKK␤ (pIKK␤) (A) or phosphorylated IB␣ (pIB␣) (B). Membranes were reprobed for GAPDH to control for protein loading. Representative blots are shown (nϭ3). Relevant molecular mass markers are indicated.
ROS are not sufficient, because in the presence of W-7 (which blocks CAM activity without interfering with the constitutive Ca 2ϩ entry that might be necessary for proper ROS generation), phosphorylation of IB␣ was totally abrogated. SKF96365, similarly to W-7, also prevented TNF␣induced phosphorylation of IKK␤ and IB␣, suggesting a mandatory requirement for constitutive Ca 2ϩ entry-mediated activation of CAM at least early in the signaling (see below). A molecular approach will be required to unequivocally identify the CAMK isoform involved and the putative downstream targets that, acting in concert with ROS, lead to IKK␤ phosphorylation and activation of NFB. Recent work showed that CAM couples receptor-regulated activity of TRPC1 and TRPC4 to thrombin-induced NFB stimulation in human and mouse endothelial cells, 29 whereas TNF␣ signaling was Ca 2ϩ -independent. Our findings represent the first evidence for a role of the Ca 2ϩ /CAM/CAMK axis in TNF␣-dependent activation of NFB in endothelial cells and the first suggesting a requirement for TRPC3 constitutive function in that process. Knockdown of TRPC3 also reduced TNF␣-induced ICAM-1 (also driven by NFB 26 ) and IL-1␤induced VCAM-1, indicating that TRPC3 may exert a more general role in NFB-dependent regulated expression of these adhesion molecules by different proatherogenic stimuli, rather than a specific function in TNF␣-induced VCAM-1. Unlike VCAM-1, TRPC3 knockdown reduced total ICAM-1 protein levels but not those in the cell surface, indicating that ICAM-1 trafficking might be slower than that of VCAM-1, precluding for changes in surface ICAM-1 to be seen after only three hours of TNF␣ treatment.
The increase in TRPC3-mediated constitutive cation influx, whole-cell ionic currents and TRPC3 protein that follows TNF␣ treatment indicates that in HCAECs augmented expression of TRPC3 in response to proatherogenic factors translates into more functional channels in the membrane. Because basal cytosolic Ca 2ϩ levels were not affected by the increase in constitutively active TRPC3 (96Ϯ7 nmol/L, with or without TNF␣ treatment), we speculate that any effect of TRPC3-mediated constitutive Ca 2ϩ influx should occur within the immediate vicinity of the channel; such localized changes may suffice to modulate signaling components in close proximity to TRPC3 without manifesting into changes in bulk cytosolic Ca 2ϩ (subject to rapid Ca 2ϩ buffering). In line with this, it should be noted that experiments involving inhibition of CAM and CAMKs were performed under constitutive Ca 2ϩ influx conditions (TNF␣ does not stimulate Ca 2ϩ entry), suggesting that highly localized elevations in submembranous Ca 2ϩ under basal conditions might be responsible for signaling to NFB, as shown in other cell types. 33 Other groups have also observed TNF␣-dependent modulation of Ca 2ϩ influx in relation to TRPC function. In airway smooth muscle cells, TNF␣ increased constitutive Ca 2ϩ entry that was abrogated by knockdown of TRPC3. 34 In those studies, TNF␣ augmented TRPC3, whereas TRPC1, -4, -5, and -6 remained unaltered. 34 TNF␣-induced TRPC1 expression was observed in human endothelial cells from dermal microvessels, umbilical vein (HUVECs), and pulmonary artery (HPAECs). 35, 36 In HUVECs and HPAECs, that was accompanied by augmented receptor-regulated Ca 2ϩ influx, but the impact of TNF␣ on constitutive influx was not examined. Our studies in HCAECs show a differential effect of TNF␣ on individual TRPC members. Whereas TRPC3, -4, and -7 proteins were increased by the cytokine, TRPC1 was drastically reduced, an observation that contrasts with the studies above. 35, 36 Although differences in experimental conditions may account for such disparate results, it is likely that responsiveness of individual TRPCs to TNF␣ actions vary, not only in different cell types but also throughout the vascular tree.
Altogether, our findings suggest that a gain in constitutively active TRPC3 may result in pathological Ca 2ϩdependent signaling, even in the absence of receptor stimulation. This prompted us to ask whether a mere increase in the number of TRPC3 channels would be sufficient to promote VCAM-1 expression. Our experiments using 2 different TRPC3 overexpression systems indicate that whereas under basal conditions high constitutive channel function did not induced VCAM-1, regulated expression was increased. In line with this, TRPC3 overexpression enhanced TNF␣induced IB␣ phosphorylation/degradation without altering basal activity. The simplest interpretation is that TRPC3 constitutive function is necessary but not sufficient and that a priming signal, such as TNF␣, might be needed. However, 2 aspects of the overexpression systems used here should be noted. First, HEK293 cells (nonendothelial) do not express VCAM-1 as robustly as HCAECs, and they always require priming with TNF␣. Second, in transient TRPC3 overexpression in HCAECs a low plasmid concentration was used; because increasing DNA copy number through plasmid copy number leads to increases in TRPC3 protein, 37 the possibility remains that if higher expression levels were attained, a threshold would be reached at which constitutive TRPC3 function per se would be sufficient to alter basal VCAM-1 levels even in the absence of a priming signal. Are there in vivo examples of biological consequences of a gain in TRPC3 constitutive activity? Studies on TRPC6 knockout mice show that compensatory upregulated expression of TRPC3 resulted in elevated contractility of aorta and cerebral arteries. 38 In mouse skeletal myocytes TRPC3 is increased by neuromuscular activity and this correlates with enhanced constitutive NFAT activity. 39 Acting as Ca 2ϩ entry gates is not the only way TRPCs can influence intracellular Ca 2ϩ . Because they are nonselective cation channels TRPCs can alter membrane potential by mediating Na ϩ influx thus modulating the driving force for Ca 2ϩ entry and/or affecting the activity of voltage-gated Ca 2ϩ channels. Also, TRPC3 is involved in modulation of IP 3 -mediated Ca 2ϩ release from endoplasmic reticulum. 40 Although the latter has not been yet demonstrated to operate in endothelial cells, it may be of particular relevance in the action of stimuli endowed with Ca 2ϩ -mobilizing properties in endothelium, such as ATP.
TRPC channels participate in myriad Ca 2ϩ -dependent events that are part of the endothelial cell physiology and are emerging as critical players in signaling events associated to cardiovascular disease. 11, 41, 42 A review of existing literature shows that the role of TRPC3 constitutive activity in cardiovascular pathophysiology has been scarcely examined or, in some instances, overlooked. The present findings underscore the potential impact of upregulated expression of constitutively active TRPC3 within the context of molecular/cellular events that are critical in the pathogenesis of coronary artery disease. Aortic root sections from atherosclerotic ApoE Ϫ/Ϫ mice showed more notorious immunoreactivity for TRPC3 than sections from wild-type animals. Although suggestive, a multitude of inflammatory mediators underlie lesion development in vivo, and thus a causal relationship between increased expression of native TRPC3 and atherogenesis cannot be established at this time. Generation of mouse models of atherosclerosis in which TRPC3 expression can be manipulated (ie, conditional transgenic or knockout animals for TRPC3) would be required to properly appreciate the contribution of TRPC3 to lesion development in vivo.
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Novelty and Significance
What Is Known?
• Recruitment of monocytes to the subendothelial milieu is a key event in atherogenesis and is mostly mediated by vascular cell adhesion molecule (VCAM)-1. • Transient receptor potential canonical (TRPC) channels are among the most important Ca 2ϩ permeable cation channels in endothelium, where they participate in both physiological and pathophysiological processes. • In recent work, we identified TRPC3, a member of the TRPC family, as an obligatory component of the mechanism underlying regulated expression of VCAM-1 in coronary endothelium, pointing for a potential role of this channel in atherogenesis.
What New Information Does This Article Contribute?
• The present work shows that, in coronary endothelium, proatherogenic stimuli induce expression of TRPC3 and that the increase in plasma membrane constitutively active TRPC3 channels mediates the Ca 2ϩ influx that supports regulated expression of VCAM-1, intercellular adhesion molecule-1, and monocyte adhesion. • Evidence is provided indicating that TRPC3-mediated constitutive Ca 2ϩ influx is coupled to activation of nuclear factor (NF)B through Ca 2ϩ -dependent activation of the calmodulin/calmodulindependent kinase axis.
Expression of TRPC3 in coronary endothelium is upregulated by proatherogenic factors. Because TRPC3 exhibits high constitutive, nonregulated activity, it was important to determine whether the contribution of TRPC3 to VCAM-1 expression and monocyte adhesion was through regulated or nonregulated function and how such activity couples to intracellular signaling. We show that not only VCAM-1 but also intercellular adhesion molecule-1 expression has an obligatory requirement for TRPC3 constitutive function. This is a highly novel concept because the participation of TRPCs in vascular inflammation has been associated with receptor-dependent channel activation rather than constitutive activity, underscoring the potential pathophysiological relevance of increased endothelial expression of constitutively active TRPC channels. Mechanistic insight is provided indicating that TRPC3-mediated constitutive Ca 2ϩ influx couples to activation of the canonical NFB pathway through Ca 2ϩdependent activation of calmodulin and calmodulin-dependent kinases. Identifying novel players in the signaling pathway that controls the expression of cell adhesion molecules is imperative to expand the spectrum of existing potential molecular targets that can be exploited to develop effective antiinflammatory therapies for atherosclerosis. The recognition of TRPC3 as a novel component in such processes represents a major contribution in that direction.
